Clovis Oncology Inc (NASDAQ:CLVS)

5.89
Delayed Data
As of Aug 22
 -0.17 / -2.81%
Today’s Change
4.98
Today|||52-Week Range
37.27
-67.20%
Year-to-Date
No recent news for Clovis Oncology Inc.

Today’s Trading

Previous close6.06
Today’s open6.06
Day’s range5.85 - 6.09
Volume2,723,132
Average volume (3 months)2,485,357
Market cap$305.5M
Data as of 4:00pm ET, 08/22/2019

Growth & Valuation

Earnings growth (last year)+3.97%
Earnings growth (this year)-5.34%
Earnings growth (next 5 years)+31.35%
Revenue growth (last year)+71.84%
P/E ratioNM
Price/Sales9.80
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
XERSXeris Pharmaceutical...-0.74-6.07%
PGNXProgenics Pharmaceut...+0.64+16.58%
ALBOAlbireo Pharma Inc-0.38-1.44%
MIRMMirum Pharmaceutical...+0.09+0.64%
Data as of 4:00pm ET, 08/22/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$1.80
Annual revenue (last year)$95.4M
Annual profit (last year)-$368.0M
Net profit margin-385.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts